Helicobacter pylori eradication for the prevention of gastric neoplasia (Q24186365)

Helicobacter pylori infectious disease

title

Helicobacter pylori eradication for the prevention of gastric neoplasia (English)

0 references

main subject

Helicobacter pylori

0 references

1 reference

1

Alexander C Ford

Alexander C

Ford

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26198377%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

4

Yuhong Yuan

Yuhong

Yuan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26198377%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

David Forman

2

David

Forman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26198377%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Richard Hunt

series ordinal

3

author given names

Richard

author last names

Hunt

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26198377%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

Paul Moayyedi

series ordinal

5

author given names

Paul

author last names

Moayyedi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26198377%20AND%20SRC:MED&resulttype=core&format=json

Cochrane Database of Systematic Reviews

14 June 2020

language of work or name

1 reference

22 July 2015

0 references

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26198377%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26198377%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

page(s)

CD005583

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26198377%20AND%20SRC:MED&resulttype=core&format=json

Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial

14 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005583.PUB2

Anti-inflammatory and tissue-protectant drug effects: results from a randomized placebo-controlled trial of gastritis patients at high risk for gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005583.PUB2

A randomized clinical trial to determine the efficacy of regimens containing clarithromycin, metronidazole, and amoxicillin among histologic subgroups for Helicobacter pylori eradication in a developing country

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005583.PUB2

A community screening program for Helicobacter pylori saves money: 10-year follow-up of a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005583.PUB2

Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005583.PUB2

A pilot study to evaluate stomach cancer risk reduction by Helicobacter pylori eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005583.PUB2

Randomised controlled trial of effects of Helicobacter pylori infection and its eradication on heartburn and gastro-oesophageal reflux: Bristol helicobacter project

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005583.PUB2

Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005583.PUB2

Helicobacter pylori infection and development of gastric cancer in Korea: long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005583.PUB2

Impact of Helicobacter pylori eradication on dyspepsia, health resource use, and quality of life in the Bristol helicobacter project: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005583.PUB2

Does Helicobacter pylori eradication therapy for peptic ulcer prevent gastric cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005583.PUB2

The cost-effectiveness of population Helicobacter pylori screening and treatment: a Markov model using economic data from a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005583.PUB2

Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: a randomised controlled trial. Leeds HELP Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005583.PUB2

Improvement in atrophic gastritis and intestinal metaplasia in patients in whom Helicobacter pylori was eradicated

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005583.PUB2

The effect of eradicating helicobacter pylori on the development of gastric cancer in patients with peptic ulcer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005583.PUB2

Helicobacter pylori infection and the development of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005583.PUB2

Rates of dyspepsia one year after Helicobacter pylori screening and eradication in a Danish population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005583.PUB2

Addressing dichotomous data for participants excluded from trial analysis: a guide for systematic reviewers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005583.PUB2

A model for gastric cancer epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005583.PUB2

Survival after gastric adenocarcinoma resection: eighteen-year experience at a single institution

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005583.PUB2

Survival of early gastric cancer in a specialized European center. Which lymphadenectomy is necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005583.PUB2

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005583.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005583.PUB2

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005583.PUB2

Chemoprevention for gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005583.PUB2

Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005583.PUB2

Helicobacter pylori: the gastric cancer problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005583.PUB2

Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005583.PUB2

Factorial trial of three interventions to reduce the progression of precancerous gastric lesions in Shandong, China: design issues and initial data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005583.PUB2

Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005583.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005583.PUB2

The benefit of mass eradication of Helicobacter pylori infection: a community-based study of gastric cancer prevention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005583.PUB2

Short and long-term survival from gastric cancer. A population-based study from a county hospital during 25 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005583.PUB2

Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005583.PUB2

Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005583.PUB2

Long term follow up of patients treated for Helicobacter pylori infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005583.PUB2

Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005583.PUB2

Helicobacter pylori infection and the risk of gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005583.PUB2

Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005583.PUB2

Morphometric evaluation of gastric antral atrophy: improvement after cure of Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005583.PUB2

Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005583.PUB2

Long-term garlic or micronutrient supplementation, but not anti-Helicobacter pylori therapy, increases serum folate or glutathione without affecting serum vitamin B-12 or homocysteine in a rural Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005583.PUB2

Role of Helicobacter pylori CagA+ strains and risk of adenocarcinoma of the stomach and esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005583.PUB2

Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005583.PUB2

An intervention trial to inhibit the progression of precancerous gastric lesions: compliance, serum micronutrients and S-allyl cysteine levels, and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005583.PUB2

Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005583.PUB2

Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005583.PUB2

A randomized factorial study of the effects of long-term garlic and micronutrient supplementation and of 2-wk antibiotic treatment for Helicobacter pylori infection on serum cholesterol and lipoproteins

21 January 2018

1 reference

12 December 2020

Eradication of Helicobacter pylori prevents cancer development in subjects with mild gastric atrophy identified by serum pepsinogen levels

1 reference

12 December 2020

Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective, randomized study

1 reference

12 December 2020

Noncardia gastric adenocarcinoma remains an important and deadly cancer in the United States: secular trends in incidence and survival

1 reference

12 December 2020

Baseline gastric mucosal atrophy is a risk factor associated with the development of gastric cancer after Helicobacter pylori eradication therapy in patients with peptic ulcer diseases

1 reference

12 December 2020

A five-year follow-up study on the pathological changes of gastric mucosa after H. pylori eradication.

1 reference

12 December 2020

Significance of Helicobacter pylori infection and gastric cancer: implications for screening.

1 reference

12 December 2020

Cost of detecting malignant lesions by endoscopy in 2741 primary care dyspeptic patients without alarm symptoms

1 reference

12 December 2020

[Present state of Japanese intervention trial of H. pylori]

1 reference

12 December 2020

Eradication of Helicobacter pylori after endoscopic resection of gastric tumors does not reduce incidence of metachronous gastric carcinoma

1 reference

12 December 2020

Unidentified curved bacilli on gastric epithelium in active chronic gastritis

1 reference

12 December 2020

Effects of selective COX-2 inhibitor and Helicobacter pylori eradication on precancerous gastric lesions

1 reference

12 December 2020

The effect of Helicobacter pylori eradication on reducing the incidence of gastric cancer

1 reference

12 December 2020

[Changes of gastric mucosa histopathology after Helicobacter pylori eradication]

1 reference

12 December 2020

Helicobacter pylori infection and the risk of gastric malignancy

1 reference

12 December 2020

Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy

1 reference

12 December 2020

Redundant Data in the Meta-analysis onHelicobacter pyloriEradication

1 reference

12 December 2020

Re: Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy

1 reference

12 December 2020

Helicobacter pylori eradication reduced the incidence of gastric cancer, especially of the intestinal type

1 reference

12 December 2020

H. pylori infection and the development of gastric cancer.

1 reference

12 December 2020

Helicobacter pylori and gastric cancer:current status of the Austrain Czech German gastric cancer prevention trial (PRISMA Study)

1 reference

12 December 2020

The changing trends of the incidence of gastric cancer after Helicobacter pylori eradication in Shandong area

1 reference

12 December 2020

Attempt to fulfil Koch's postulates for pyloric Campylobacter.

1 reference

12 December 2020

10.1002/14651858.CD005583.PUB2

Identifiers

DOI

2 references

Consolidated OpenCitations Corpus – April 2017

289214

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26198377%20AND%20SRC:MED&resulttype=core&format=json

release_2doxkvomfjg3rigfujlgdywg7y

14 June 2020

Fatcat ID

0 references

289214

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26198377%20AND%20SRC:MED&resulttype=core&format=json

14 June 2020

2 references

Consolidated OpenCitations Corpus – April 2017

289214